24 | Bombesin Receptors (Bombesin Receptor)IBA
11/2021
-
01/2005 |
23 | Peptides (Polypeptides)IBA
11/2021
-
02/2003 |
17 | Radioisotopes (Radionuclides)IBA
11/2021
-
01/2012 |
11 | Cholecystokinin (Pancreozymin)IBA
03/2022
-
10/2005 |
11 | Neprilysin (Neutral Endopeptidase)IBA
11/2020
-
01/2014 |
9 | GastrinsIBA
03/2022
-
10/2005 |
9 | phosphoramidonIBA
11/2020
-
01/2014 |
9 | BombesinIBA
03/2019
-
01/2005 |
8 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2022
-
01/2014 |
6 | Somatostatin Receptors (Somatostatin Receptor)IBA
11/2020
-
02/2004 |
5 | Biological ProductsIBA
03/2019
-
10/2012 |
4 | NeurotensinIBA
10/2020
-
07/2006 |
4 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
08/2014
-
01/2006 |
4 | Octreotide (Sandostatin)FDA LinkGeneric
01/2014
-
01/2006 |
3 | 68Ga-SB3IBA
11/2021
-
01/2017 |
3 | Peptide Receptors (Peptide Receptor)IBA
01/2019
-
01/2012 |
3 | LigandsIBA
01/2019
-
02/2008 |
3 | minigastrinIBA
03/2016
-
10/2005 |
3 | Cholecystokinin B ReceptorIBA
03/2016
-
10/2005 |
2 | Chelating AgentsIBA
03/2022
-
07/2017 |
2 | sacubitril and valsartan sodium hydrate drug combinationIBA
11/2020
-
10/2020 |
2 | Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2020
-
06/2020 |
2 | Vasopeptidase InhibitorsIBA
10/2020
-
12/2016 |
2 | Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2020
-
06/2020 |
2 | Lisinopril (Prinivil)FDA LinkGeneric
10/2020
-
06/2020 |
2 | Gallium-68IBA
01/2019
-
12/2018 |
2 | RadiopharmaceuticalsIBA
08/2016
-
02/2004 |
2 | Gastrin-Releasing PeptideIBA
11/2013
-
02/2008 |
2 | 99mTc-demotideIBA
02/2006
-
01/2006 |
1 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
03/2022 |
1 | aniline (aniline hydrobromide)IBA
10/2021 |
1 | diglycolic acidIBA
10/2021 |
1 | LBQ657IBA
11/2020 |
1 | IsotopesIBA
11/2020 |
1 | Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
11/2020 |
1 | Protease Inhibitors (Protease Inhibitor)IBA
10/2020 |
1 | Peptide Hydrolases (Proteases)FDA Link
06/2020 |
1 | Trastuzumab (Herceptin)FDA Link
12/2019 |
1 | Pharmaceutical PreparationsIBA
01/2019 |
1 | Lutetium-177IBA
01/2019 |
1 | Yttrium-90IBA
01/2019 |
1 | IndiumIBA
12/2018 |
1 | AmidesIBA
09/2017 |
1 | TriazolesIBA
09/2017 |
1 | ProdrugsIBA
12/2016 |
1 | Estrogen ReceptorsIBA
05/2015 |
1 | Hormones (Hormone)IBA
12/2014 |
1 | EnzymesIBA
11/2014 |
1 | Lysine (L-Lysine)FDA Link
11/2014 |
1 | Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2014 |
1 | Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
03/2012 |
1 | pentetreotide (OctreoScan)FDA Link
01/2012 |
1 | Pentetic Acid (DTPA)FDA LinkGeneric
01/2012 |
1 | Neurotensin Receptors (Neurotensin Receptor)IBA
10/2011 |
1 | Atrial Natriuretic Factor Receptors (Atrial Natriuretic Factor Receptor)IBA
01/2011 |
1 | AndrogensIBA
02/2003 |